SaferWorldbyDesign Webinar: A Novel Framework for Teasing Out Mechanisms of DILI

Tuesday 23 June 2020

16-16:45 CEST - (7 am California, 10 am New York, 3 pm London, 4 pm Zurich, 7:30 pm New Delhi, 11 pm Tokyo)

In this webinar presented by InSphero, Liver Toxicology Team Leader Dr. Monika Kijanska will introduce a framework for mechanistic toxicology investigations, based on a suite of causality assays developed for our 3D InSight™ Liver Toxicology Platform. Monika will discuss how to design experimental programs that help validate relationships between events that trigger toxic responses and identify adverse outcome pathways implicated in drug-induced liver injury, and present example data generated using our liver toxicology platform. You will learn:

  • How one simple, proven causality assay applied using different models at different time points can help tease out mechanisms of DILI
  • How to tune and adapt 3D-optimized causality assays for a wide range of pathways using specific pathway modulators for DILI-specific mechanistic investigations and mechanism based screening
  • Advantages of using a scalable, robust, and versatile 3D in vitro platform for liver toxicology studies.

Presented by a partner of the recently established EU-ToxRisk Commercial Platform for New Approach Methods (NAMs) in Safety Assessment

Latest Tweets

Edelweiss Connect (2 weeks ago)
RT @barryhardy: Cosmetics Assessment is an area with a strong need for use of non-animal testing methods and continuing innovation in testi…
Edelweiss Connect (2 weeks ago)
RT @barryhardy: Discussion of COVID-19 work using modelling and informatics 19 CEST, Tuesday 22 September, OpenTox 2020 virtual conference…
Edelweiss Connect (2 weeks ago)
Join us for the 2020 OpenTox Virtual Conference Sep 21-25 The OpenTox 2020 Conference activity will be supported b… https://t.co/azV6JH5sJI
Edelweiss Connect (2 months ago)
#SaferWorldbyDesign Use of alternative skin models for animal-free safety and efficacy testing in dermatology resea… https://t.co/I9wkhBRjZm
Edelweiss Connect (2 months ago)
RT @barryhardy: The activities of drug inactive ingredients on biological targets This #OpenTox Webinar (Thursday 8 August) will include a…

Get in touch

  • Address: Edelweiss Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland

USA office

  • Address: Edelweiss Connect Inc
    Research Triangle Park NC
    800 Park Offices Dr
    Durham, NC 27709
    USA